Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease.
about
Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growthMyeloid-derived suppressor cells: linking inflammation and cancerInhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 proteinThe role of NKT cells in tumor immunityProinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cellsB7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinomaTumour progression and metastasisCyclooxygenase-2 promotes tumor growth and suppresses tumor immunityMyeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor MicroenvironmentThe impact of the myeloid response to radiation therapyMyeloid-derived suppressor cells and anti-tumor T cells: a complex relationshipNeoplastic "Black Ops": cancer's subversive tactics in overcoming host defensesInflammatory networks and immune surveillance of pancreatic carcinomaBone specific immunity and its impact on metastasisImproving cancer immunotherapy by targeting the STATe of MDSCsImmune heterogeneity in neuroinflammation: dendritic cells in the brainMechanical disruption of tumors by iron particles and magnetic field application results in increased anti-tumor immune responsesCoordinated regulation of myeloid cells by tumoursMacrophage-specific chemokines induced via innate immunity by amino acid copolymers and their role in EAEContext-Specific and Immune Cell-Dependent Antitumor Activities of α1-AntitrypsinMicroenvironmental regulation of tumor progression and metastasisWhat differentiates normal lung repair and fibrosis? Inflammation, resolution of repair, and fibrosisTumors as organs: complex tissues that interface with the entire organismMyeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells.Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer.Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine.Development of optical probes for in vivo imaging of polarized macrophages during foreign body reactions.Regulation of macrophage arginase expression and tumor growth by the Ron receptor tyrosine kinaseMechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells.Antigen-specific CD4(+) T cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling.Lung tumor growth is stimulated in IFN-gamma-/- mice and inhibited in IL-4Ralpha-/- mice.Stat6 Promotes Intestinal Tumorigenesis in a Mouse Model of Adenomatous Polyposis by Expansion of MDSCs and Inhibition of Cytotoxic CD8 Response.Polyamine-blocking therapy reverses immunosuppression in the tumor microenvironment.Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells.MDSCs mediate angiogenesis and predispose canine mammary tumor cells for metastasis via IL-28/IL-28RA (IFN-λ) signaling.Infiltration of alternatively activated macrophages in cancer tissue is associated with MDSC and Th2 polarization in patients with esophageal cancer.HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironmentIDO is a nodal pathogenic driver of lung cancer and metastasis development.HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cellsPolyamine blockade promotes antitumor immunity.
P2860
Q21560837-362AE4CD-05E9-48EF-B920-01D4746D957AQ24641811-4165CC0D-E89C-4F59-B5BA-95675F8F329BQ24641894-B8EE0316-0E02-4168-B65D-06562247E3B3Q24648939-4C218553-F8CF-485E-A58E-3764E5F9925EQ24658240-14AB0430-BD36-42F1-940F-3E038CE89EB7Q24676809-6F9E59D4-55B3-4BAC-9E23-33F377C46E5EQ26766468-185312EC-E2F2-448D-9382-23C2DBACDFFCQ26778534-E957BAFD-17E2-45B5-A7C6-D0143BBD3A17Q26799126-2EB1DC60-CE8A-4ED1-B543-3BE94A4998B9Q26851643-CCF3F311-4F1D-4C97-A7BF-6295BFA8404FQ27000087-D94E10AF-2BA7-45BF-8632-6FABB6DEF4F5Q27001081-5BF3509D-9E71-4738-95D0-7D706A5CB0BFQ27013983-75976A10-D605-4385-885C-7100EC996378Q27022883-B1852CD1-752F-499B-B482-BADEBBF65607Q28066797-63E74381-6F11-470A-9878-2E5499BC46D8Q28385127-DAB3C668-2C72-47B0-B8EC-E386F08BA104Q28390368-18447F01-5D84-40D5-A23C-9E2C29E015B4Q28395157-59EE02EB-0556-4EB2-9FF6-BF4A0B1B4B53Q28741374-49FD039B-C04C-4D55-B3E8-D6CB580EF15CQ28817846-3792ADD0-F57F-43EE-96C2-D0C09F1E4ACAQ29615504-26BE6A58-190F-45A8-9C49-FA08C0D2A930Q30439833-3A89D428-1620-40CD-9E56-51F5740D785FQ30495528-885CB76E-9D97-4AAD-9D85-7B2899A497C6Q33567728-6BCA0262-EF4C-4A78-98E1-D1F355A9EA6DQ33584851-491DFF3C-66C7-42A4-B5E0-A26148799B68Q33584867-EAD35EFE-597D-4B87-86B0-0796653E0A47Q33700270-0C0BCE86-FAC8-4FC7-B483-4320655CDBD0Q33703886-EF11BDD3-F666-4ED8-A052-C0145303510EQ33707270-D91E75A1-478F-434F-A1B5-7097601A3471Q33772651-6F79D825-40FA-4717-B07C-82FA23B196D7Q33814920-D46339C7-1CE2-43D8-8D35-3A0DD12BD23CQ33842749-19C7602A-787A-4A5D-A63F-BED41932B357Q33914402-08EF73C3-6CF4-467A-A947-0563EA256452Q33919954-16938AD2-0A5B-42AC-AB9F-77B175898953Q33975551-B36EDAA1-BAAD-4A8F-BFD4-D9AD58878297Q34075192-EB546F43-E704-4145-81E1-9F4BEF04D4F1Q34243443-E00C220C-D123-4E86-A2FE-543C89AA712EQ34289698-F7EBA851-5928-487E-A6A6-25AE6B9E4A57Q34353413-D5E9DC94-0F3E-41D0-B36F-6C934BDE3497Q34414218-342FF71F-A4CE-4B4F-AD0F-7F9948777D6A
P2860
Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Reduction of myeloid-derived s ...... stablished metastatic disease.
@en
type
label
Reduction of myeloid-derived s ...... stablished metastatic disease.
@en
prefLabel
Reduction of myeloid-derived s ...... stablished metastatic disease.
@en
P2093
P1476
Reduction of myeloid-derived s ...... stablished metastatic disease.
@en
P2093
Pratima Sinha
Suzanne Ostrand-Rosenberg
Virginia K Clements
P304
P356
10.4049/JIMMUNOL.174.2.636
P407
P577
2005-01-01T00:00:00Z